Evolus, Inc. (28) | Business Finance (12)

Browse by Subcategory

Recent Contracts

Loan Agreement, dated as of December 14, 2021, by and among Evolus, Inc. (as Borrower and a Credit Party), BioPharma Credit PLC (as Collateral Agent), BPCR Limited Partnership (as... (Filed With SEC on December 14, 2021)
Registration Rights Agreement, dated February 18, 2021, by and between Evolus, Inc. and Medytox, Inc (Filed With SEC on May 12, 2021)
Share Issuance Agreement, dated February 18, 2021, by and between Evolus Inc. and Medytox, Inc (Filed With SEC on May 12, 2021)
Convertible Promissory Note Conversion Agreement, dated March 23, 2021, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on May 12, 2021)
Underwriting Agreement, dated (Filed With SEC on April 26, 2021)
Subordination Agreement. dated July 6, 2020, by and among Evolus, Inc., Oxford Finance, LLC and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on July 7, 2020)
Form of Convertible Promissory Note by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on July 7, 2020)
Convertible Promissory Note Purchase Agreement, dated July 6, 2020, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on July 7, 2020)
Underwriting Agreement, dated November 6, 2019, by and between Evolus, Inc. and SVB Leerink LLC, Stifel, Nicolaus & Company, Incorporated and Cantor Fitzgerald & Co., as... (Filed With SEC on November 12, 2019)
First Amendment to Loan and Security Agreement dated as of July 18, 2019, by and between the Company and Oxford Finance, LLC (Filed With SEC on August 12, 2019)
Underwriting Agreement, dated as of May 15, 2019, among the Registrant, ALPHAEON Corporation and Morgan Stanley & Co. LLC (Filed With SEC on May 21, 2019)
Loan and Security Agreement dated as of March 15, 2019, by and between the Company and Oxford Finance, LLC (Filed With SEC on May 1, 2019)